Pfizer and Moderna are reportedly expanding the Covid vaccine studies of children to better understand rare side effects
Pfizer and Moderna are expanding the sizes of their Covid-19 vaccine trials in children ages five to 11,Monday, characterizing the move as a precautionary measure to better understand rare side effects—including heart inflammation problems—that have turned up in some young people.Multiple anonymous sources toldthat vaccine makers are moving to expand their ongoing clinical trials at the request of the Food and Drug Administration .
The agency reportedly indicated the size and scope of the current studies were inadequate to detect the rare side effects of myocarditis and pericarditis that have been identified in a very small number of coronavirus vaccine recipients under 30. last month showing around 500 of the 1,200 Americans who developed heart inflammation issues after receiving mRNA vaccines were under the age of 30.
This amounts to less than 13 cases per one million second doses administered of these diseases, which—marked by symptoms like chest pain and shortness of breath—typically clear up within a few weeks, but in a small number of cases can be chronic. What To Watch For It’s currently unclear how expanding the size of the trials will impact the timeline for getting these vaccines formally approved for use in children. The FDA
earlier this month it expects the emergency authorization for Covid-19 vaccines in children under 12 to come in early to midwinter. it found a “likely association” between a rare heart inflammatory condition in young people and the coronavirus vaccine, though the reported cases were minute compared with total inoculations and the risk of getting the diseases are even greater among those with Covid-19.
México Últimas Noticias, México Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
WSJ News Exclusive | Covid-19 Pill Race Heats Up as Japanese Firm Vies With Pfizer, MerckJapan’s Shionogi has started human trials for a once-a-day drug designed to neutralize the coronavirus in less than a week as Pfizer and Merck carry out later-stage tests.
Leer más »
Mixed AstraZeneca-Pfizer shot boosts COVID antibody level - studyA mixed vaccination of first AstraZeneca (AZN.L) and then a Pfizer (PFE.N) COVID-19 shot boosted neutralizing antibody levels by six times compared with two AstraZeneca doses, a study from South Korea showed.
Leer más »
Pfizer and Moderna to expand size of vaccine studies in 5- to 11-year-oldsPfizer and Moderna are expanding the size of their COVID-19 vaccine studies in children ages 5 to 11, according to a new report.
Leer más »
Pfizer And Moderna To Expand Studies Of Vaccines In 5- To 11-Year-OldsAt the request of the FDA, the vaccine makers are expanding their trials with young children, seeking to better detect very rare heart issues.
Leer más »
Pfizer And Moderna To Expand Studies Of Vaccines In 5- To 11-Year-OldsAt the request of the FDA, the vaccine makers are expanding their trials with young children, seeking to better detect very rare heart issues.
Leer más »